DnB Asset Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-57,103
Closed -$529K 665
2023
Q2
$529K Sell
57,103
-69,806
-55% -$590K ﹤0.01% 633
2023
Q1
$1.04M Sell
126,909
-2,297
-2% -$25.4K 0.01% 608
2022
Q4
$1.44M Buy
129,206
+4,891
+4% +$56.9K 0.01% 554
2022
Q3
$1.47M Sell
124,315
-4,000
-3% -$60.6K 0.01% 549
2022
Q2
$1.96M Buy
128,315
+17,100
+15% +$308K 0.01% 519
2022
Q1
$2.35M Buy
111,215
+3,671
+3% +$79.1K 0.01% 518
2021
Q4
$2.54M Sell
107,544
-17,597
-14% -$377K 0.01% 519
2021
Q3
$2.51M Buy
125,141
+6,172
+5% +$126K 0.02% 498
2021
Q2
$2.39M Buy
118,969
+13,420
+13% +$287K 0.02% 513
2021
Q1
$2.25M Buy
105,549
+43,692
+71% +$940K 0.02% 518
2020
Q4
$1.35M Sell
61,857
-8,264
-12% -$161K 0.01% 532
2020
Q3
$1.24M Sell
70,121
-25,300
-27% -$471K 0.01% 496
2020
Q2
$1.79M Buy
95,421
+4,907
+5% +$86.9K 0.02% 408
2020
Q1
$1.56M Sell
90,514
-10,100
-10% -$211K 0.02% 396
2019
Q4
$2.12M Buy
+100,614
New +$2.04M 0.02% 442

Other funds holding MPT

DnB Asset Management's MPT Position: Q3 2023 in Review

DnB Asset Management sold out of Medical Properties Trust (MPT) in Q3 2023, closing a stake of 57,103 shares — an estimated $529K sold.

DnB Asset Management first reported a position in MPT in Q4 2019 and held it in 15 quarters. The position peaked at $2.54M in Q4 2021. 541 funds tracked by Wall St. Rank hold MPT as of Q3 2023.

  • DnB Asset Management reported no remaining Medical Properties Trust position as of Q3 2023 after selling out during the quarter.
  • DnB Asset Management sold 57,103 Medical Properties Trust shares in Q3 2023, an estimated $529K.
  • DnB Asset Management first reported a position in Medical Properties Trust in Q4 2019 and held it in 15 quarters.
  • DnB Asset Management's Medical Properties Trust position peaked at $2.54M in Q4 2021.
  • 541 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2023.

Based on DnB Asset Management's 13F filing for Q3 2023, filed 13 Oct 2023.